DIAN-TU Overview and Next Steps, Part 1

Description: An update on the results of clinical trials being conducted by the DIAN Trials Unit, using the drugs gantenerumab and solanezumab
Runtime: 00:21:51

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director
Speaker organization: Washington University in St. Louis

Event: 2020 Virtual DIAD Family Conference
Year: 2020

Search tags: gantenerumab, public-private partnership, amyloid hypothesis, amyloid plaques, neurodegeneration, biomarkers, tau tangles, primary prevention, cognitive function, clinical trials, DIAN-TU-001 Trial, solanezumab, drug dosing, preclinical Alzheimer’s